[HTML][HTML] Methods for exploring and eliciting patient preferences in the medical product lifecycle: a literature review
V Soekhai, C Whichello, B Levitan, J Veldwijk… - Drug discovery today, 2019 - Elsevier
Highlights•Preference studies are becoming increasingly important within the medical
product decision-making context.•Currently, there is limited understanding of the range of …
product decision-making context.•Currently, there is limited understanding of the range of …
Clinical implications of numeracy: theory and practice
W Nelson, VF Reyna, A Fagerlin… - Annals of behavioral …, 2008 - academic.oup.com
Background Low numeracy is pervasive and constrains informed patient choice, reduces
medication compliance, limits access to treatments, impairs risk communication, and affects …
medication compliance, limits access to treatments, impairs risk communication, and affects …
GRADE Guidelines: 19. Assessing the certainty of evidence in the importance of outcomes or values and preferences—Risk of bias and indirectness
Abstract Objectives The Grading of Recommendations Assessment, Development, and
Evaluation (GRADE) working group defines patient values and preferences as the relative …
Evaluation (GRADE) working group defines patient values and preferences as the relative …
[HTML][HTML] Advanced therapy medicinal products and health technology assessment principles and practices for value-based and sustainable healthcare
B Jönsson, G Hampson, J Michaels, A Towse… - The European journal of …, 2019 - Springer
Background Advanced therapy medicinal products (ATMPs) are beginning to reach
European markets, and questions are being asked about their value for patients and how …
European markets, and questions are being asked about their value for patients and how …
Review of high‐risk features of cutaneous squamous cell carcinoma and discrepancies between the American Joint Committee on Cancer and NCCN Clinical …
SL Skulsky, B O'Sullivan, O McArdle, M Leader… - Head & …, 2017 - Wiley Online Library
Cutaneous squamous cell carcinoma (SCC) is a malignancy that arises from epidermal
keratinocytes. Although the majority of cutaneous SCC cases are easily treated without …
keratinocytes. Although the majority of cutaneous SCC cases are easily treated without …
Improved vision-related function after ranibizumab treatment of neovascular age-related macular degeneration: results of a randomized clinical trial
TS Chang, NM Bressler, JT Fine… - Archives of …, 2007 - jamanetwork.com
Objective To examine the effects of ranibizumab on patient-reported visual function using
the National Eye Institute Visual Function Questionnaire 25 (NEI VFQ-25) in patients with …
the National Eye Institute Visual Function Questionnaire 25 (NEI VFQ-25) in patients with …
Characterizing structural uncertainty in decision analytic models: a review and application of methods
L Bojke, K Claxton, M Sculpher, S Palmer - Value in Health, 2009 - Elsevier
BACKGROUND: The characterization of uncertainty is critical in cost-effectiveness analysis,
particularly when considering whether additional evidence is needed. In addition to …
particularly when considering whether additional evidence is needed. In addition to …
Cost-benefit analysis and health care evaluations
RJ Brent - 2004 - books.google.com
Professor Brent s book is a superb and much-needed text in the field of health care
evaluation. The economic approaches for appraisal of health care programs are presented …
evaluation. The economic approaches for appraisal of health care programs are presented …
Patient quality of life on quotidian hemodialysis
AP Heidenheim, N Muirhead, L Moist… - American Journal of …, 2003 - Elsevier
BACKGROUND:: Studies have shown improved quality of life for hemodialysis (HD) patients
after changing from conventional thrice-weekly HD treatment to more frequent HD …
after changing from conventional thrice-weekly HD treatment to more frequent HD …
[HTML][HTML] Improving the use of research evidence in guideline development: 10. Integrating values and consumer involvement
Abstract Background The World Health Organization (WHO), like many other organisations
around the world, has recognised the need to use more rigorous processes to ensure that …
around the world, has recognised the need to use more rigorous processes to ensure that …